乳腺癌幸存者影像监测:数字乳腺摄影与数字乳腺断层合成的比较
本研究回顾性分析乳腺癌幸存者数字乳腺摄影(9019次检查)与数字乳腺断层合成(22887次检查)的筛查表现,DBT组异常判读率更低(5.8% vs 6.2%,OR 0.80,P=0.001)、特异度更高(95.0% vs 94.7%,OR 1.23,P=0.003),但癌检出率无差异(8.3/1000 vs 10.6/1000,OR 0.76,P=0.07)。
要点
- DBT用于乳腺癌幸存者监测时异常判读率低于数字乳腺摄影,特异度更高。
- DBT与数字乳腺摄影的癌检出率无显著差异(8.3/1000 vs 10.6/1000,P=0.07)。
- 两组筛查检出浸润癌占比相似(DBT组74% vs 数字乳腺摄影组72%,P=0.69)。
核心结论
- 在乳腺癌幸存者中,数字乳腺断层合成筛查较数字乳腺摄影假阳性结果更少、特异度更高,但未影响癌检出。
研究设计与样本
- 回顾性研究,比较DBT实施前后的乳腺筛查钼靶,数字乳腺摄影组为2008年3月至2011年2月,DBT组为2013年1月至2017年12月。
- 数字乳腺摄影组9019次检查,DBT组22887次检查,共纳入8170名女性(平均年龄62岁±12)。
- 钼靶由乳腺影像放射科医生在计算机辅助检测辅助下判读,采用多变量逻辑回归模型比较两组表现指标和肿瘤特征。
关键影像表现/征象
- 原文未报告影像征象。
诊断标准与关键数值
- DBT组异常判读率为5.8%(1331/22887次检查),数字乳腺摄影组为6.2%(563/9019次检查),OR 0.80(95%CI 0.71,0.91),P=0.001。
- DBT组特异度为95.0%(21502/22644次检查),数字乳腺摄影组为94.7%(8424/8891次检查),OR 1.23(95%CI 1.07,1.41),P=0.003。
- DBT组癌检出率为8.3/1000次检查,数字乳腺摄影组为10.6/1000次检查,OR 0.76(95%CI 0.57,1.02),P=0.07。
- 筛查检出浸润癌占筛查检出癌的比例:DBT组74%(140/189例癌),数字乳腺摄影组72%(69/96例癌),P=0.69。
- 86例间期癌中,58%(50/86例)有症状表现,33%(28/86例)经筛查MRI检出。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Among breast cancer survivors, detecting a breast cancer when it is asymptomatic (rather than symptomatic) improves survival; thus, imaging surveillance in these patients is warranted. Digital breast tomosynthesis (DBT) is used for screening, but data on DBT for surveillance in this high-risk population are limited. Purpose To determine whether DBT leads to improved screening performance metrics when compared with two-dimensional digital mammography among breast cancer survivors. Materials and Methods In this study, screening mammograms obtained in breast cancer survivors before and after DBT implementation were retrospectively reviewed (March 2008-February 2011 for the digital mammography group; January 2013-December 2017 for the DBT group). Mammograms were interpreted by breast imaging radiologists with the assistance of computer-aided detection. Performance metrics and tumor characteristics between the groups were compared using multivariable logistic regression models. Results The digital mammography and DBT groups were composed of 9019 and 22 887 mammographic examinations, respectively, in 8170 women (mean age, 62 years ± 12 [standard deviation]). In the DBT group, the abnormal interpretation rate was lower (5.8% [1331 of 22 887 examinations] vs 6.2% [563 of 9019 examinations]; odds ratio [OR], 0.80; 95% CI: 0.71, 0.91; P = .001) and specificity was higher (95.0% [21 502 of 22 644 examinations] vs 94.7% [8424 of 8891 examinations]; OR, 1.23; 95% CI: 1.07, 1.41; P = .003) than in the digital mammography group. The cancer detection rates did not differ (8.3 per 1000 examinations with DBT vs 10.6 with digital mammography; OR, 0.76; 95% CI: 0.57, 1.02; P = .07). The proportions of screening-detected invasive cancers, versus in situ cancers, were similar (74% [140 of 189 cancers] in the DBT group vs 72% [69 of 96 cancers] in the digital mammography group; P = .69). Of 86 interval cancers, 58% (50 of 86 cancers) manifested with symptoms, and 33% (28 of 86 cancers) were detected at screening MRI. Conclusion Among breast cancer survivors, screening with digital breast tomosynthesis led to fewer false-positive results and higher specificity but did not affect cancer detection. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Hooley and Butler in this issue.
引用
- Bahl M, Mercaldo S, McCarthy AM, et al. Imaging Surveillance of Breast Cancer Survivors with Digital Mammography versus Digital Breast Tomosynthesis. Radiology. 2020. PMID: 33350890. doi:10.1148/radiol.2020201854
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。